Synergistic contribution of CD14 and HLA loci in the susceptibility to Buerger disease

Human Genetics

Volumn 122, Issue 3-4, 2007, Pages 367-372

  Chen, Zhiyong ^a   Takahashi, Megumi ^a   Naruse, Taeko ^a   Nakajima, Toshiaki ^a   Chen, Yi Wen ^a   Inoue, Yoshinori ^a   Ishikawa, Isao ^a,b   Iwai, Takehisa ^a   Kimura, Akinori ^a  

^a Tokyo Medical and Dental University ^*  (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA DP ANTIGEN; HLA DPB1 ANTIGEN; HLA DR ANTIGEN; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ARTICLE; BUERGER DISEASE; CONTROLLED STUDY; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC MARKER; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HUMAN; INNATE IMMUNITY; JAPANESE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; RISK FACTOR;

ALLELES; ANTIGENS, CD14; CASE-CONTROL STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA ANTIGENS; HLA-B ANTIGENS; HLA-DP ANTIGENS; HLA-DR ANTIGENS; HUMANS; ODDS RATIO; PERIODONTITIS; POLYMORPHISM, GENETIC; THROMBOANGIITIS OBLITERANS;

BACTERIA (MICROORGANISMS);

EID: 35448960863     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-007-0408-1     Document Type: Article

References (34)

1. Adar R, Papa MZ, Halpern Z, Mozes M, Shoshan S, Sofer B, Zinger H, Dayan M, Mozes E (1983) Cellular sensitivity to collagen in thromboangiitis obliterans. N Engl J Med 308:1113-1116
2. Aerbajinai W, Tsuchiya T, Kimura A, Yasukochi Y, Numano F (1996) HLA class II DNA typing in Buerger's disease. Int J Cardiol 54(Suppl):S197-S202
3. Arroyo-Espliguero R, Avanzas P, Jeffery S, Kaski JC (2004) CD14 and toll-like receptor 4: A link between infection and acute coronary events? Heart 90:983-988
4. Ates A, Yekeler I, Ceviz M, Erkut B, Pac M, Basoglu A, Kocak H (2006) One of the most frequent vascular diseases in northeastern of Turkey: thromboangiitis obliterans or Buerger's disease (experience with 344 cases). Int J Cardiol 111:147-153
5. Baldini M, Lohman IC, Halonen M, Erickson RP, Holt PG, Martinez FD (1999) A polymorphism* in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 20:976-83
6. Beutler B (2000) Tlr4: Central component of the sole mammalian LPS sensor. Curr Opin Immunol 12:20-26
7. Buerger L (1952) Thrombo-angitis obliterans; a study of the vascular lesions leading to presenile spontaneous gangrene. Am J Med 13:526-532
8. Chen YW, Iwai T, Umeda M, Nagasawa T, Huang Y, Takeuchi Y, Ishikawa I (2007) Elevated IgG titers to periodontal pathogens related to Buerger disease. Int J Cardiol doi:10.1016/j.ijcard.2006.11.032
9. Chun YH, Chun KR, Olguin D, Wang HL (2005) Biological foundation for periodontitis as a potential risk factor for atherosclerosis. J Periodontal Res 40:87-95
10. Dorn BR, Burks JN, Seifert KN, Progulske-Fox A (2000) Invasion of endothelial and epithelial cells by strains of Porphyromonas gingivalis. FEMS Microbiol Lett 187:139-144
11. Folwaczny M, Glas J, Török H-P, Fricke K, Folwaczny (2004) The CD14 - 159C-to-T promoter polymorphism in periodontal disease. J Clin Periodontol 31:991-995
12. Hada M, Sakihama T, Kamiya K, Tasaka K, Ueno A (1993) Cellular and humoral immune responses to vascular components in thromboangiitis obliterans. Angiology 44:533-540
13. Hirayama K, Matsushita S, Kikuchi I, Iuchi M, Ohta N, Sasazuki T (1987) HLA-DQ is epistatic to HLA-DR in controlling the immune response to schistosomal antigen in humans. Nature 327:426-430
14. Hohda S, Kimura A, Sasaoka T, Hayashi T, Ueda K, Yasunami M, Okabe M, Fukuda N, Kurosawa T, Izumi T (2003) Association study of the CD14 polymorphism with myocardial infarction in Japanese populations. Jpn Heart J 44:613-622
15. Hubacek JA, Pit'ha J, Skodova Z, Stanek V, Poledne R (1999) C-260)->T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 99:3218-3220
16. Iwai T, Inoue Y, Umeda M, Huang Y, Kurihara N, Koike M, Ishikawa I (2005) Oral bacteria in the occluded arteries of patients with Buerger disease. J Vasc Surg 42:107-115
17. James JA, Poulton KV, Haworth SE, Payne D, McKay IJ, Clarke FM, Hughes FJ, Linden GJ (2007) Polymorphisms of TLR4 but not CD14 are associated with a decreased risk of aggressive periodontitis. J Clin Periodontol 34:111-117
18. Kamikawaji N, Fujisawa K, Yoshizumi H, Fukunaga M, Yasunami M, Kimura A, Nishimura Y, Sasazuki T (1991) HLA-DQ-restricted CD4+ T cells specific to streptococcal antigens present in low but not in high responders. J Immunol 146:2560-2567
19. Kimura A, Kobayashi Y, Takahashi M, Ohbuchi N, Kitamura H, Nakamura T, Satoh M, Sasaoka T, Hiroi S, Arimura T, Akai J, Aerbajinai W, Yasukochi Y, Numano F (1998) MICA gene polymorphism in Takayasu's arteritis and Buerger's disease. Int J Cardiol 66(Suppl 1):S107-S113
20. Kobayashi M, Nishikimi N, Komori K (2006) Current pathological and clinical aspects of Buerger's disease in Japan. Ann Vasc Surg 20:148-156
21. Kondo T, Ohno M, Shimokata K, Iino S, Inden Y, Murohara T, Hirai M (2003) CD14 promoter polymorphism is associated with acute myocardial infarction resulting from insignificant coronary artery stenosis. Heart 89:931-932
22. Laine ML, Morré SA, Murillo LS, von Winkelhoff A-J, Peña AS (2005) CD14 and TLR4 gene polymorphisms in adult peiodontitis. J Dent Res 84:1042-1046
23. McCluskey J, Peh CA (1999) The human leukocyte antigens and clinical medicine: And overview. Rev Immunogenet 1:3-20
24. Numano F, Sasazuki T, Koyama T, Shimokado K, Takeda Y, Nishimura Y, Mutoh M (1986) HLA in Buerger's disease. Exp Clin Immunogenet 3:195-200
25. Ohyama H, Takashiba S, Oyaizu K, Nagai A, Naruse T, Inoko H, Kurihara H, Murayama Y (1996) HLA class II genotypes associated with early-onset periodontitis: DQB1 molecule primarily confers susceptibility to the disease. J Periodontol 67:888-894
26. Olin JW (2000) Thromboangiitis obliterans (Buerger's disease). N Engl J Med 343:864-869
27. Saito S, Ota S, Yamada E, Inoko H, Ota M (2000) Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population. Tissue Antigens 56:522-529
28. Sengar DP, Hampton N, Goldstein R, Sengar AS (1995) Comprehensive typing of HLA-DPB1 alleles by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Clin Invest Med 18:465-472
29. Stein J, Reichert S, Gautsch A, Maculla HKG (2003) Are there HLA combinations typical supporting for or making resistant against aggressive and/or chronic periodontitis? J Periodont Res 38:508-517
30. Svejgaard A, Ryder LP (1994) HLA and disease associations: Detecting the strongest association. Tissue Antigens 43:18-27
31. Takahashi M, Kobayashi Y, Ichiki M, Ouchi H, Numano F, Kimura An (1999) HLA-linked susceptibility and resistance to Buerger's disease in Japanese. MHC 5:7-12
32. Takashiba S, Ohyama H, Oyaizu K, Kogoe-Kato N, Maruyama Y (1999) HLA genetics for diagnosis of susceptibility to early-onset periodontitis. J Periodont Res 34:374-378
33. Tanaka K (1998) Pathology and pathogenesis of Buerger's disease. Int J Cardiol 66(Suppl 1):S237-S242
34. Vainas T, Stassen FRM, Bruggeman CA, Welten R, van den Akker L, Kitslaar P, Pena AS, Morre SA (2006) Synergistic effect of Toll-like receptor 4 and CD14 polymorphisms on the total atherosclerosis burden in patients with peripheral arterial disease. J Vasc Surg 44:326-332